The effect of mexidol (M) and nitroxymexidol (NM) on the activity of phosphodiesterase of cyclic guanosine monophosphate (PDEcGMP), regulation of lipid peroxidation (LPO), and antiradical and antihypoxic activity was investigated under normoxia and normobaric hypercapnic hypoxia conditions. Reversible and noncompetitive inhibition of the hydrolytic function of PDEcGMP by M and NM was revealed. The Ki value for M was 1 ×10–4 M; for NM, 1 ×10–5 M, i.e., NM was 10 times more active than M. It was shown that the lifetime of experimental animals in a closed space increased by 36% under the action of M as compared with that of the control group while it increased by 53% for NM. The ventricular contraction time increased by 137% for NM. The atrial contraction time increased from 31 min in the control to 52 and 57 min for M and NM, respectively.
Similar content being viewed by others
References
T. N. Roudneva, N. Sanina, D. Mischenko, et al., Nitric Oxide: Biol. Chem., 19, Supplement, 43 (2008).
L. V. Tat’yanenko, O. V. Dobrokhotova, R. A. Kotel’nikov, et al., Pharm. Chem. J., 45(6), 329 – 332 (2011).
L. M. Baider, O. L. Belaya, Z. V. Kuropteva, et al., Vopr. Biol. Med. Farm. Khim., No. 3, 44 – 47 (2009).
R. G. Glushkov, S. D. Yuzhakov, M. V. Alekseev, et al., Khim.-farm. Zh., 45(3), 3 – 8 (2011); Pharm. Chem. J., 45(3), 131 –136 (2011).
B. S. Fedorov, M. A. Fadeev, V. N. Varfolomeev, et al., RU Pat. No. 2,394,815, Jul. 20, 2010, “Nitroxy-succinate 2-ethyl-6-methyl-3-oxypyridine (versions of use) and method for producing said compound.”
V. K. Promonenkov and V. P. Rutkovskij, RU Pat. No. 2,211,833, Sep. 10, 2003, “Method for preparing 2-ethyl-6-methyl-3-hydroxy-pyridine.”
R. E. Liberzon, T. T. Shchekoldina, and O. S. Vatolkina, Vopr. Med. Khim., 4, 526 – 530 (1977).
J. L. Bailey, Techniques in Protein Chemistry, Elsevier Pub. Co., New York (1967) [Russian translation pp. 53 – 60].
I. B. Berezin and A. A. Khlesov, Practical Course in Chemical and Enzyme Kinetics [in Russian], Izd. MGU, Moscow (1976), pp. 77 – 84.
R. A. Kotel’nikova, D. V. Mishchenko, D. A. Zhokhova, et al., High Energy Chem., 43(7), 582 – 586 (2010).
T. F. Slater, Methods Enzymol., 105, 283 – 293 (1984).
R. F. Kotel’nikova and I. I. Faingol’d, Izv. Akad. Nauk, Ser. Khim., 6, 1146 – 1150 (2011).
F. Rind, Mod. Drug Discovery, Nov / Dec, 31 (1998).
V. G. Granik and N. B. Grigor’ev, Izv. Akad. Nauk, Ser. Khim., 8, 1268 – 1272 (2002).
V. G. Granik and N. B. Grigor’ev, Nitric Oxide (NO). New Pathway to Drug Discovery [in Russian], Vuzovskaya Kniga, Moscow (2004), p. 360.
R. A. Kotel’nikova, I. I. Faingold, D. A. Poletaeva, et al., Russ. Chem. Bull., 60(6), 1172 – 1176 (2011).
A. I. Kotel’nikov, G. N. Bogdanov, D. V. Mishchenko, et al., Al’manakh Klin. Med., 1(17), 199 – 200 (2008).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 48, No. 7, pp. 3 – 6, July, 2014.
Rights and permissions
About this article
Cite this article
Tat’yanenko, L.V., Dobrokhotova, O.V., Varfolomeev, V.N. et al. Effect of Mexidol and Nitroxymexidol on Phosphodiesterase Activity, Some Oxidation Processes, and Hypoxia Resistance. Pharm Chem J 48, 417–420 (2014). https://doi.org/10.1007/s11094-014-1123-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-014-1123-6